GRAS Notices
-
GRN No. 774
Glutaminase from Bacillus licheniformis produced in Bacillus licheniformis
Intended Use: | Intended for use as a processing aid in various food ingredients such as casein, whey protein, soy and wheat protein, breads, noodles, tofu, fish, cheese and seasonings at levels that are the minimum amount necessary to achieve the desired technical effect. |
---|---|
Basis: | Scientific procedures |
Notifier: | Novozymes North America, Inc. |
Notifier Address: |
77 Perrys Chapel Church Road, Box 576 Franklinton, NC 27525 |
GRAS Notice (releasable information): | GRN 774 (in PDF) (1.3 MB) |
Date of closure: | Nov 26, 2018 |
FDA's Letter: | FDA has no questions (in PDF) (73 kB) |
-